Induction of donor-specific tolerance in living donor kidney transplant recipients through clinical MIC cell infusion - a phase I study (TOL-1)

被引：0

作者：

Morath, Christian ^{[1
]}

Schmitt, Anita ^{[2
]}

Kleist, Christian ^{[3
]}

Daniel, Volker ^{[4
]}

Opelz, Gerhard ^{[4
]}

Suesal, Caner ^{[4
]}

Kaelble, Florian ^{[1
]}

Sommerer, Claudia ^{[1
]}

Wang, Lei ^{[2
]}

Hueckelhoven, Angela ^{[2
]}

Mehrabi, Arianeb ^{[5
]}

Merle, Uta ^{[6
]}

da Silva, Luiza Pego ^{[1
]}

Mueller-Tidow, Carsten ^{[2
]}

Zeier, Martin ^{[1
]}

Schaier, Matthias ^{[1
]}

Schmitt, Michael ^{[2
]}

Terness, Peter ^{[4
]}

机构：

[1] Univ Clin Heidelberg, Div Nephrol, Heidelberg, Germany

[2] Univ Clin Heidelberg, Dept Internal Med 5, Heidelberg, Germany

[3] Univ Clin Heidelberg, Dept Nucl Med, Heidelberg, Germany

[4] Heidelberg Univ, Inst Immunol, Heidelberg, Germany

[5] Univ Clin Heidelberg, Allgemein Viszeral & Transplantat Chirurg, Heidelberg, Germany

[6] Univ Clin Heidelberg, Dept Internal Med 4, Heidelberg, Germany

来源：

BONE MARROW TRANSPLANTATION | 2018年 / 53卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

P111

引用

页码：229 / 230

页数：2

共 50 条

[31] Single Fixed Low Dose of Rituximab as Induction Therapy for Kidney Transplant Recipients Highly Sensitized with Donor-Specific Antibodies
Tomita, Y.
Iwadoh, K.
Nakajima, I.
Fuchinoue, S.
Koyama, I.
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 281 - 281
[32] Induction of donor-specific tolerance by chimeric class I MHC molecules bearing donor alpha(1) helical amino acids
Wang, M
Yu, J
Wang, ME
Tian, L
Stepkowski, SM
Kahan, BD
TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 1224 - 1225
[33] Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients
Garcia-Morales, R
Carreno, M
Mathew, J
Cirocco, R
Zucker, K
Ciancio, G
Burke, G
Roth, D
Temple, D
Fuller, L
Esquenazi, V
Eskind, L
Kenyon, NS
Ricordi, C
Tzakis, A
Miller, J
TRANSPLANTATION, 1998, 65 (07) : 956 - 965
[34] Clinical Significance of Pretransplant Donor-Specific Antibodies in the Setting of Negative Cell-Based Flow Cytometry Crossmatching in Kidney Transplant Recipients
Adebiyi, O. O.
Gralla, J.
Klem, P.
Freed, B.
Davis, S.
Wiseman, A. C.
Cooper, J. E.
AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (12) : 3458 - 3467
[35] Long Term Follow-Up of a Phase 2 Clinical Trial to Induce Tolerance in Living Donor Kidney Transplant Recipients.
Leventhal, J.
Galvin, J.
Mathew, J.
Gallon, L.
Belshe, D.
Gibson, M.
Ravindra, K.
Horwitz, M.
Ildstad, S.
AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 510 - 511
[36] Interim Results of a Phase 1 Trial of Treg Adoptive Cell Transfer (TRACT) in Living Donor Kidney Transplant Recipients
Leventhal, J.
LeFever, A.
Skaro, A.
Gallon, L.
Mathew, J.
Stare, D.
Konieczna, I.
He, J.
Johnson, G.
AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
[37] The detrimental effect of donor-specific antibodies is irrespective of its level in highly-immunized living donor kidney transplant recipients: A case-control series
Tramper, T.
Roelen, D. L.
Brand-Schaaf, S. H.
Kal-van Gestel, J. A.
Kho, M. M. L.
Reinders, M. E. J.
Roodnat, J. I.
van de Wetering, J.
Betjes, M. G. H.
de Weerd, A. E.
FRONTIERS IN IMMUNOLOGY, 2023, 13
[38] Tolerance induction in HLA disparate living donor kidney transplantation by facilitating cell-enriched donor stem cell Infusion: The importance of durable chimerism
Leventhal, Joseph R.
Ildstad, Suzanne T.
HUMAN IMMUNOLOGY, 2018, 79 (05) : 272 - 276
[39] Impact of Rituximab Induction Therapy on Donor-specific Anti-HLA Antibodies in Abo-compatible Kidney Transplant Recipients
Yagisawa, T.
Kanzawa, T.
Unagami, K.
Furusawa, M.
Inui, M.
Ishida, H.
Tanabe, K.
AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 702 - 702
[40] Analysis of T-cell alloantigen response via a direct pathway in kidney transplant recipients with donor-specific antibodies
Iwahara, Naoya
Hotta, Kiyohiko
Iwami, Daiki
Tanabe, Tatsu
Hirose, Takayuki
Shinohara, Nobuo
TRANSPLANTATION, 2024, 108 (9S)

← 1 2 3 4 5 →